Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Provisional standardization of hepcidin assays: creating a traceability chain with a primary reference material, candidate reference method and a commutable secondary reference material.

Diepeveen LE, Laarakkers CMM, Martos G, Pawlak ME, Uğuz FF, Verberne KESA, van Swelm RPL, Klaver S, de Haan AFJ, Pitts KR, Bansal SS, Abbas IM, Fillet M, Lefebvre T, Geurts-Moespot AJ, Girelli D, Castagna A, Herkert M, Itkonen O, Olbina G, Tomosugi N, Westerman ME, Delatour V, Weykamp CW, Swinkels DW.

Clin Chem Lab Med. 2018 Nov 29. pii: /j/cclm.ahead-of-print/cclm-2018-0783/cclm-2018-0783.xml. doi: 10.1515/cclm-2018-0783. [Epub ahead of print]

PMID:
30485171
2.

Comparability of Lipoprotein Particle Number Concentrations Across ES-DMA, NMR, LC-MS/MS, Immunonephelometry, and VAP: In Search of a Candidate Reference Measurement Procedure for apoB and non-HDL-P Standardization.

Delatour V, Clouet-Foraison N, Gaie-Levrel F, Marcovina SM, Hoofnagle AN, Kuklenyik Z, Caulfield MP, Otvos JD, Krauss RM, Kulkarni KR, Contois JH, Remaley AT, Vesper HW, Cobbaert CM, Gillery P.

Clin Chem. 2018 Oct;64(10):1485-1495. doi: 10.1373/clinchem.2018.288746. Epub 2018 Aug 7.

PMID:
30087138
3.

Regulatory context and validation of assays for clinical mass spectrometry proteomics (cMSP) methods.

Hirtz C, Bros P, Brede C, Lescuyer P, Maceski AM, Vialaret J, Delatour V, Lehmann S; IFCC Working Group on Clinical Quantitative Mass Spectrometry Proteomics (WG-cMSP).

Crit Rev Clin Lab Sci. 2018 Aug;55(5):346-358. doi: 10.1080/10408363.2018.1470159. Epub 2018 May 23.

PMID:
29792094
4.

Apolipoprotein B measurement: Need for standardization.

Contois JH, Delatour V.

J Clin Lipidol. 2018 Mar - Apr;12(2):264-265. doi: 10.1016/j.jacl.2018.02.017. Epub 2018 Mar 5. No abstract available.

PMID:
29606396
5.

IFCC Working Group Recommendations for Assessing Commutability Part 2: Using the Difference in Bias between a Reference Material and Clinical Samples.

Nilsson G, Budd JR, Greenberg N, Delatour V, Rej R, Panteghini M, Ceriotti F, Schimmel H, Weykamp C, Keller T, Camara JE, Burns C, Vesper HW, MacKenzie F, Miller WG; IFCC Working Group on Commutability.

Clin Chem. 2018 Mar;64(3):455-464. doi: 10.1373/clinchem.2017.277541. Epub 2018 Jan 18.

6.

IFCC Working Group Recommendations for Assessing Commutability Part 3: Using the Calibration Effectiveness of a Reference Material.

Budd JR, Weykamp C, Rej R, MacKenzie F, Ceriotti F, Greenberg N, Camara JE, Schimmel H, Vesper HW, Keller T, Delatour V, Panteghini M, Burns C, Miller WG; IFCC Working Group on Commutability.

Clin Chem. 2018 Mar;64(3):465-474. doi: 10.1373/clinchem.2017.277558. Epub 2018 Jan 18.

PMID:
29348164
7.

IFCC Working Group Recommendations for Assessing Commutability Part 1: General Experimental Design.

Miller WG, Schimmel H, Rej R, Greenberg N, Ceriotti F, Burns C, Budd JR, Weykamp C, Delatour V, Nilsson G, MacKenzie F, Panteghini M, Keller T, Camara JE, Zegers I, Vesper HW; IFCC Working Group on Commutability.

Clin Chem. 2018 Mar;64(3):447-454. doi: 10.1373/clinchem.2017.277525. Epub 2018 Jan 18.

8.

Letter to the Editor regarding "Achieving comparability with IFCC reference method for the measurement of hemoglobin A1c by use of an improved isotope-dilution mass spectrometry method".

Clouet-Foraison N, Gillery P, Delatour V.

Anal Bioanal Chem. 2017 Sep;409(24):5789-5790. doi: 10.1007/s00216-017-0513-5. Epub 2017 Aug 3. No abstract available.

PMID:
28776074
9.

Advanced lipoprotein testing for cardiovascular diseases risk assessment: a review of the novel approaches in lipoprotein profiling.

Clouet-Foraison N, Gaie-Levrel F, Gillery P, Delatour V.

Clin Chem Lab Med. 2017 Aug 28;55(10):1453-1464. doi: 10.1515/cclm-2017-0091. Review.

10.

Absolute Quantification of Bionanoparticles by Electrospray Differential Mobility Analysis: An Application to Lipoprotein Particle Concentration Measurements.

Clouet-Foraison N, Gaie-Levrel F, Coquelin L, Ebrard G, Gillery P, Delatour V.

Anal Chem. 2017 Feb 21;89(4):2242-2249. doi: 10.1021/acs.analchem.6b02909. Epub 2017 Jan 30.

PMID:
28192939
11.

Multicenter Evaluation of Cystatin C Measurement after Assay Standardization.

Bargnoux AS, Piéroni L, Cristol JP, Kuster N, Delanaye P, Carlier MC, Fellahi S, Boutten A, Lombard C, González-Antuña A, Delatour V, Cavalier E; Société Française de Biologie Clinique (SFBC).

Clin Chem. 2017 Apr;63(4):833-841. doi: 10.1373/clinchem.2016.264325. Epub 2017 Feb 10.

12.

In vitro monitoring of amyloid β-peptide oligomerization by Electrospray differential mobility analysis: An alternative tool to evaluate Alzheimer's disease drug candidates.

Brinet D, Gaie-Levrel F, Delatour V, Kaffy J, Ongeri S, Taverna M.

Talanta. 2017 Apr 1;165:84-91. doi: 10.1016/j.talanta.2016.12.011. Epub 2016 Dec 7.

PMID:
28153323
13.

Impurity determination for hepcidin by liquid chromatography-high resolution and ion mobility mass spectrometry for the value assignment of candidate primary calibrators.

Bros P, Josephs RD, Stoppacher N, Cazals G, Lehmann S, Hirtz C, Wielgosz RI, Delatour V.

Anal Bioanal Chem. 2017 Apr;409(10):2559-2567. doi: 10.1007/s00216-017-0202-4. Epub 2017 Jan 30.

PMID:
28138741
14.

Quantification of hepcidin-25 in human cerebrospinal fluid using LC-MS/MS.

Delaby C, Bros P, Vialaret J, Moulinier A, Delatour V, Gabelle A, Lehmann S, Hirtz C.

Bioanalysis. 2017 Feb;9(4):337-347. doi: 10.4155/bio-2016-0240. Epub 2017 Jan 20.

PMID:
28106476
15.

Commutability Assessment of External Quality Assessment Materials with the Difference in Bias Approach: Are Acceptance Criteria Based on Medical Requirements too Strict?

Delatour V, Liu Q, Vesper HW; LNE-LABAC Working Group on Commutability.

Clin Chem. 2016 Dec;62(12):1670-1671. No abstract available.

16.

Clinical mass spectrometry proteomics (cMSP) for medical laboratory: What does the future hold?

Lehmann S, Brede C, Lescuyer P, Cocho JA, Vialaret J, Bros P, Delatour V, Hirtz C; IFCC Working Group on Clinical Quantitative Mass Spectrometry Proteomics (WG-cMSP).

Clin Chim Acta. 2017 Apr;467:51-58. doi: 10.1016/j.cca.2016.06.001. Epub 2016 Jun 2. Review.

PMID:
27265523
17.

Reference Method and Reference Material Are Necessary Tools to Reveal the Variability of Cystatin C Assays.

Bargnoux AS, Kuster N, Delatour V, Delanaye P, González-Antuña A, Cristol JP, Piéroni L, Cavalier E; Société Française de Biologie Clinique.

Arch Pathol Lab Med. 2016 Feb;140(2):117-8. doi: 10.5858/arpa.2015-0198-LE. No abstract available.

PMID:
26910214
18.

Antibody-free quantification of seven tau peptides in human CSF using targeted mass spectrometry.

Bros P, Vialaret J, Barthelemy N, Delatour V, Gabelle A, Lehmann S, Hirtz C.

Front Neurosci. 2015 Sep 1;9:302. doi: 10.3389/fnins.2015.00302. eCollection 2015.

19.

Quantitative detection of amyloid-β peptides by mass spectrometry: state of the art and clinical applications.

Bros P, Delatour V, Vialaret J, Lalere B, Barthelemy N, Gabelle A, Lehmann S, Hirtz C.

Clin Chem Lab Med. 2015 Sep 1;53(10):1483-93. doi: 10.1515/cclm-2014-1048. Review.

20.

Determination of Cystatin C in human serum by isotope dilution mass spectrometry using mass overlapping peptides.

González-Antuña A, Rodríguez-González P, Ohlendorf R, Henrion A, Delatour V, García Alonso JI.

J Proteomics. 2015 Jan 1;112:141-55. doi: 10.1016/j.jprot.2014.09.005. Epub 2014 Sep 16.

PMID:
25230103
21.

Performance of GFR estimating equations in African Europeans: basis for a lower race-ethnicity factor than in African Americans.

Flamant M, Vidal-Petiot E, Metzger M, Haymann JP, Letavernier E, Delatour V, Karras A, Thervet E, Boffa JJ, Houillier P, Stengel B, Vrtovsnik F, Froissart M; NephroTest Study Group.

Am J Kidney Dis. 2013 Jul;62(1):182-4. doi: 10.1053/j.ajkd.2013.03.015. Epub 2013 Apr 20. No abstract available.

PMID:
23608543
22.

Enzymatic but not compensated Jaffe methods reach the desirable specifications of NKDEP at normal levels of creatinine. Results of the French multicentric evaluation.

Boutten A, Bargnoux AS, Carlier MC, Delanaye P, Rozet E, Delatour V, Cavalier E, Hanser AM, Froissart M, Cristol JP, Piéroni L; Société Française de Biologie Clinique.

Clin Chim Acta. 2013 Apr 18;419:132-5. doi: 10.1016/j.cca.2013.01.021. Epub 2013 Feb 13.

PMID:
23415696
23.

Validation of a reference method for total cholesterol measurement in human serum and assignation of reference values to proficiency testing samples.

Heuillet M, Lalere B, Peignaux M, De Graeve J, Vaslin-Reimann S, Pais De Barros JP, Gambert P, Duvillard L, Delatour V.

Clin Biochem. 2013 Mar;46(4-5):359-64. doi: 10.1016/j.clinbiochem.2012.11.026. Epub 2012 Dec 5.

PMID:
23219742
24.

Continuous improvement of medical test reliability using reference methods and matrix-corrected target values in proficiency testing schemes: application to glucose assay.

Delatour V, Lalere B, Saint-Albin K, Peignaux M, Hattchouel JM, Dumont G, De Graeve J, Vaslin-Reimann S, Gillery P.

Clin Chim Acta. 2012 Nov 20;413(23-24):1872-8. doi: 10.1016/j.cca.2012.07.016. Epub 2012 Jul 31. Erratum in: Clin Chim Acta. 2012 Dec 24;414:182-4.

PMID:
22885373
25.

A multicentric evaluation of IDMS-traceable creatinine enzymatic assays.

Piéroni L, Delanaye P, Boutten A, Bargnoux AS, Rozet E, Delatour V, Carlier MC, Hanser AM, Cavalier E, Froissart M, Cristol JP; Société Française de Biologie Clinique.

Clin Chim Acta. 2011 Nov 20;412(23-24):2070-5. doi: 10.1016/j.cca.2011.07.012. Epub 2011 Jul 22.

26.

Arp2/3 controls the motile behavior of N-WASP-functionalized GUVs and modulates N-WASP surface distribution by mediating transient links with actin filaments.

Delatour V, Helfer E, Didry D, Lê KH, Gaucher JF, Carlier MF, Romet-Lemonne G.

Biophys J. 2008 Jun;94(12):4890-905. doi: 10.1529/biophysj.107.118653. Epub 2008 Mar 7.

Supplemental Content

Loading ...
Support Center